Danofloxacin free base

CAS No. 112398-08-0

Danofloxacin free base( Danofloxacine | Danofloxacin | Danofloxacino )

Catalog No. M21121 CAS No. 112398-08-0

Danofloxacin is a fluoroquinolone antibiotic used in veterinary medicine.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 28 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Danofloxacin free base
  • Note
    Research use only, not for human use.
  • Brief Description
    Danofloxacin is a fluoroquinolone antibiotic used in veterinary medicine.
  • Description
    Danofloxacin is a fluoroquinolone antibiotic used in veterinary medicine.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Danofloxacine | Danofloxacin | Danofloxacino
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    112398-08-0
  • Formula Weight
    357.38
  • Molecular Formula
    C19H20FN3O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?H2O : 4.59 mg/mL (12.84 mMu)
  • SMILES
    CN1CC2CC1CN2c1cc2c(cc1F)c(=O)c(C(=O)O)cn2C1CC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Yang Y Zhang Y Li J et al. Susceptibility breakpoint for Danofloxacin against swine Escherichia coli[J]. Bmc Veterinary Research 2019 15(1).
molnova catalog
related products
  • Egg yolk phosphatidy...

    Lecithins, egg can be used as an excipient. Pharmaceutical excipients, or pharmaceutical auxiliaries, refer to other chemical substances used in the pharmaceutical process other than pharmaceutical ingredients. Pharmaceutical excipients generally refer to inactive ingredients in pharmaceutical preparations, which can improve the stability, solubility and processability of pharmaceutical preparations. Pharmaceutical excipients also affect the absorption, distribution, metabolism, and elimination (ADME) processes of co-administered drugs.

  • Burosumab

    Burosumab(KRN23) is a human monoclonal antibody targeting fibroblast growth factor 23 (FGF23) for the treatment of cutaneous-skeletal hypophosphatemic syndrome (CSHS) and tumor-induced osteochondrosis.

  • Nerol

    Nerol is a monoterpene found in many essential oils such as lemon balm and hop.Nerol can lessened the severity of ouabain-triggered arrhythmias in mammalian heart.